GlassScriptPhysician profile
Tyler James Ferguson
NPI 1982269486
$1,799.23
in general payments reported to CMS, 2019-2025
20 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $330 · 2023: $492 · 2024: $508 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,468.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $742.98 | 2022-2025 | Clareon, Clareon Panoptix Pro |
| Glaukos Corporation | $334.52 | 2023 | Iaccess Precision Blade |
| Abbvie INC. | $147.83 | 2023-2025 | |
| Inspire Medical Systems, INC. | $76.82 | 2025 | Inspire |
| Exact Sciences Corporation | $76.60 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $64.44 | 2024-2025 | Wegovy |
| Abbott Laboratories | $45.69 | 2025 | Freestyle Libre 3, Cardiomems |
| Glaxosmithkline, LLC. | $37.26 | 2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $35.66 | 2024 | Zepbound, Mounjaro |
| Imperative Care, INC | $34.85 | 2024 | Hotshot Controller |
| Bausch & Lomb Americas INC. | $29.58 | 2022 | |
| Medtronic, INC. | $27.64 | 2025 | Inceptiv |
| Esperion Therapeutics, INC. | $21.46 | 2024 | Nexletol |
| Tolmar, INC. | $20.72 | 2025 | Jatenzo |
| 3b Medical, INC. | $19.47 | 2025 | Luna |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $19.22 | 2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $18.22 | 2024 | |
| Sumitomo Pharma America, INC. | $17.25 | 2024 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $15.00 | 2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $14.02 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.